LC-MS/MS Method for the Determination of Tenofovir from Plasma

Similar documents
SPE-LC-MS/MS Method for the Determination of Nicotine, Cotinine, and Trans-3-hydroxycotinine in Urine

LC-MS/MS Method for the Determination of 21 Opiates and Opiate Derivatives in Urine

LC-MS/MS Method for the Determination of Raloxifene and its Glucuronide Metabolites from Human Plasma Using SPE Micro Elution

Robust extraction, separation, and quantitation of structural isomer steroids from human plasma by SPE-UHPLC-MS/MS

Quantitative Analysis of THC and Main Metabolites in Whole Blood Using Tandem Mass Spectrometry and Automated Online Sample Preparation

High-Throughput, Cost-Efficient LC-MS/MS Forensic Method for Measuring Buprenorphine and Norbuprenorphine in Urine

Fast and easy separation of 23 drugs of abuse. including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS

The Investigation of Factors Contributing to Immunosuppressant Drugs Response Variability in LC-MS/MS Analysis

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

Results of Using Re-washed Vials and Closures

Evaluation of an LC-MS/MS Research Method for the Analysis of 33 Benzodiazepines and their Metabolites

MS/MS as an LC Detector for the Screening of Drugs and Their Metabolites in Race Horse Urine

Impurity Profiling of Carbamazepine by HPLC/UV

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Testing robustness: Immunosuppressant drugs in blood with a TSQ Quantis MS for clinical research

Analysis of Testosterone, Androstenedione, and Dehydroepiandrosterone Sulfate in Serum for Clinical Research

Rapid and sensitive UHPLC screening for water soluble vitamins in sports beverages

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

Vitamin D Metabolite Analysis in Biological Samples Using Agilent Captiva EMR Lipid

Quantitative Analysis of Vit D Metabolites in Human Plasma using Exactive System

Application Note. Author. Abstract. Introduction. Food Safety

Extraction of Multiple Mycotoxins From Grain Using ISOLUTE Myco prior to LC-MS/MS Analysis

Sample Concentration and Analysis of Human Hormones in Drinking Water

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Dayana Argoti, Kerry Hassell, Sarah J. Fair, and Joseph Herman Thermo Fisher Scientific, Franklin, MA, USA

LC-MS/MS quantitative analysis of Polyunsaturated Omega 3, 6,7 and 9 Fatty Acids in Serum for

Rapid and sensitive UHPLC screening of additives in carbonated beverages with a robust organic acid column

GC-MS/MS Analysis of Benzodiazepines Using Analyte Protectants

Determination of 6-Chloropicolinic Acid (6-CPA) in Crops by Liquid Chromatography with Tandem Mass Spectrometry Detection. EPL-BAS Method No.

Extraction of a Comprehensive Steroid Panel from Human Serum Using ISOLUTE. SLE+ Prior to LC/MS-MS Analysis

Determination of Amantadine Residues in Chicken by LCMS-8040

Comparison of Biotage Extrahera vs. Manual Sample Processing Using a Vacuum Manifold

Comparison of Full Scan MS2 and MS3 Linear Ion Trap Approaches for Quantitation of Vitamin D

Application Note. Abstract. Authors. Pharmaceutical

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

Extraction of 25-hydroxy Vitamin D from Serum Using ISOLUTE. PLD+ Prior to LC-MS/MS Analysis

Bioanalytical Quantitation of Biotherapeutics Using Intact Protein vs. Proteolytic Peptides by LC-HR/AM on a Q Exactive MS

Rapid and Accurate LC-MS/MS Analysis of Nicotine and Related Compounds in Urine Using Raptor Biphenyl LC Columns and MS-Friendly Mobile Phases

A RAPID AND SENSITIVE ANALYSIS METHOD OF SUDAN RED I, II, III & IV IN TOMATO SAUCE USING ULTRA PERFORMANCE LC MS/MS

New Solvent Grade Targeted for Trace Analysis by UHPLC-MS

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

Increased Identification Coverage and Throughput for Complex Lipidomes

Determination of Patulin in Apple Juice Using SPE and UHPLC-MS/MS Analysis

Use of a Tandem Mass Spectrometry Research Method for the Analysis of Amino Acids and Acylcarnitines in Dried Blood Spots

Reduced Ion Suppression and Improved LC/MS Sensitivity with Agilent Bond Elut Plexa

Robust and Fast Analysis of Tobacco-Specific Nitrosamines by LC-MS/MS

Detection of Low Level of Chloramphenicol in Milk and Honey with MIP SPE and LC-MS-MS

Rapid Analysis of Water-Soluble Vitamins in Infant Formula by Standard-Addition

Analysis of anti-epileptic drugs in human serum using an Agilent Ultivo LC/TQ

DETERMINATION OF CANNABINOIDS, THC AND THC-COOH, IN ORAL FLUID USING AN AGILENT 6490 TRIPLE QUADRUPOLE LC/MS

A Robustness Study for the Agilent 6470 LC-MS/MS Mass Spectrometer

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

GlycanPac AXR-1 Columns

UPLC-MS/MS Analysis of Azole Antifungals in Serum for Clinical Research

Efficient Quantitative Analysis of THC and Metabolites in Human Plasma Using Agilent Captiva EMR Lipid and LC-MS/MS

Dienes Derivatization MaxSpec Kit

A High Sensitivity UPLC/MS/MS Method for the Analysis of Clopidogrel and Clopidogrel Carboxylic Acid Metabolite in Human K 2 EDTA Plasma

Authors. Abstract. Introduction. Environmental

Quantification of lovastatin in human plasma by LC/ESI/MS/MS using the Agilent 6410 Triple Quadrupole LC/MS system

Comprehensive Study of SLE as a Sample. Preparation Tool for Bioanalysis

Analytes. Sample Preparation Procedure. Introduction. Format: Sample Pre-treatment. Sample Loading. Analyte Extraction and Derivatization.

Analytical Method for 2, 4, 5-T (Targeted to Agricultural, Animal and Fishery Products)

Measuring Phytosterols in Health Supplements by LC/MS. Marcus Miller and William Schnute Thermo Fisher Scientific, San Jose, CA, USA

Author. Introduction. Abstract

Analysis of Rosuvastatin in Dried Blood Spot and Plasma Using ACQUITY UPLC with 2D Technology

O O H. Robert S. Plumb and Paul D. Rainville Waters Corporation, Milford, MA, U.S. INTRODUCTION EXPERIMENTAL. LC /MS conditions

Improved Isolation and Analysis of Mycotoxins from Cereals, Beer and Wine

LC/MS/MS of Trichothecenes and Zearalenone in Wheat Using Different Sample Prep Methods

Extraction of 11-nor-9-carboxy-tetrahydrocannabinol from Hydrolyzed Urine by ISOLUTE. SLE+ Prior to GC/MS Analysis

Providing a Universal, One-step Alternative to Liquid-Liquid Extraction in Bioanalysis

Quantification of Budesonide Using UPLC and Xevo TQ-S

The Raptor HILIC-Si Column

Supporting Information

4.5 Minute Analysis of Benzodiazepines in Urine and Whole Blood Using LC/MS/MS and an Ultra Biphenyl Column

Shuguang Li, Jason Anspach, Sky Countryman, and Erica Pike Phenomenex, Inc., 411 Madrid Ave., Torrance, CA USA PO _W

Analysis of Cholesterol-Lowering Drugs (Statins) Using Dried Matrix Spot Technology

Enhanced LC-MS Sensitivity of Vitamin D Assay by Selection of Appropriate Mobile Phase

Fig. 1: Chemical structure of arachidonic acid COOH CH 3

Simple Method (IS-MRM) to Monitor Lysophospholipids and Phospholipids During LC-MS Method Development via In-Source CID

A Definitive Lipidomics Workflow for Human Plasma Utilizing Off-line Enrichment and Class Specific Separation of Phospholipids

DEXAMETHASONE. First draft prepared by Bruno LE BIZEC, Nantes, France

Dry eye disease commonly known as atopic keratoconjunctivitis is an autoimmune disease of

Application Note LCMS-108 Quantitation of benzodiazepines and Z-drugs in serum with the EVOQ TM LC triple quadrupole mass spectrometer

Pesticide Residue Analysis in Whole Milk by QuEChERS and LC-MS/MS

Integrated Targeted Quantitation Method for Insulin and its Therapeutic Analogs

Achieving Secure Sealing and Instrument Handling in 9 mm Screw Thread Chromatography Vials

Author. Introduction. Small Molecule Pharmaceuticals & Generics

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

UPLC/MS Monitoring of Water-Soluble Vitamin Bs in Cell Culture Media in Minutes

Matrix Factor Determination with the Waters Regulated Bioanalysis System Solution

Reducing Sample Volume and Increasing Sensitivity for the Quantification of Human Insulin and 5 Analogs in Human Plasma Using ionkey/ms

Offline and online sample extraction for the quantification of benzodiazepines in human plasma or serum for clinical research

Direct Analysis of Urinary Opioids and Metabolites by Mixed-Mode µelution SPE Combined with UPLC/MS/MS for Forensic Toxicology

Fast and simultaneous analysis of ethanol metabolites and barbiturates using the QTRAP 4500 LC-MS/MS system

Extraction of Synthetic and Naturally Occurring Cannabinoids in Urine Using SPE and LC-MS/MS

Challenges in Developing an Ultra-Sensitive Bioanalytical Method for Ethinylestradiol in Human Plasma

Determination of Fusarium Mycotoxins in Wheat, Maize and Animal Feed Using an Online TurboFlow and Orbitrap LC/MS Method

Transcription:

LC-MS/MS Method for the Determination of Tenofovir from Plasma Kimberly Phipps, Thermo Fisher Scientific, Runcorn, Cheshire, UK Application Note 687 Key Words SPE, SOLA CX, Hypersil GOLD, tenofovir Abstract A liquid chromatography-tandem mass spectrometry method for tenofovir from plasma has been developed. Using Thermo Scientific TM SOLA TM CX plates, sample preparation is fast and efficient, giving excellent recovery levels for the compound. Separation was carried out on a Thermo Scientific TM Hypersil GOLD TM UHPLC column with a cycle time of 3 minutes. Good chromatographic peak shape and linearity over the dynamic range 1 to 00 ng/ml was achieved with excellent recovery and reproducibility. Introduction Tenofovir (Figure 1) belongs to a class of antiretroviral drugs known as nucleotide analogue reverse transcriptase inhibitors (NRTIs), which block reverse transcriptase, an enzyme crucial to viral production. Tenofovir is marketed under the name Viread. SOLA products are revolutionary solid phase extraction (SPE) devices. This first-in-class SPE product range introduces next generation, innovative technological advancements, giving unparalleled performance characteristics compared to conventional SPE, phospholipid, and protein precipitation products. This includes: Higher levels of reproducibility Higher levels of extract cleanliness Reduced solvent requirements Increased sensitivity SOLA SPE plates or cartridges have significant advantages when analyzing compounds in complex matrices, particularly in high-throughput bioanalytical and clinical research laboratories where reduced failure rates, higher analysis speed, and lower solvent requirements are critical. SOLA products superior performance gives higher confidence in analytical results and lowers cost without compromising ease-of-use or requiring complex method development. compounds that give notoriously poor peak shape on traditional silica-based chemistries. Hypersil GOLD media provides a stationary phase with C18 selectivity and a predictable elution order but can provide new capabilities such as improved peak shape, increased peak capacity, and greater sensitivity, especially for trace compound analysis. Obtaining symmetrical peak shapes is critical to ensuring that optimum resolution and sensitivity are Figure 1: Tenofovir Hypersil GOLD columns offer excellent peak shape. Based on highly pure silica, Hypersil GOLD columns provide very symmetrical peaks, even when analyzing

2 achieved for basic pharmaceutical compounds. Hypersil GOLD columns use proprietary bonding technology to make certain that symmetrical peaks are obtained, producing data with the highest confidence in the accuracy and quality of results. Experimental Details Consumables Fisher Scientific TM LC-MS grade water W/011217 Fisher Scientific LC-MS grade methanol M/4062/17 Fisher Scientific LC-MS grade acetonitrile A/0626/17 Fisher Scientific Analytical grade acetic acid A/0360/25 Fisher Scientific TM Optima TM formic acid A117-50 Fisher Scientific Analytical grade ammonia solution A/3295/PB05 Fisher Scientific Reagent grade ammonium acetate A/3440/50 Mass Spec Certified Target DP 2 ml clear screw thread vial, ID patch, MSCERT4000-34W blue cap with bonded PTFE/silicone septum Sample Handling Equipment Thermo Scientifc 96 well plate vacuum manifold 603-351 Thermo Scientifc TM UltraVap TM CLS-229070 Sample Pretreatment A standard spiking solution (tenofovir) was prepared in methanol / water (50:50 v/v) for each concentration of calibrator and quality control needed. 0 µl of blank plasma was taken. For standards and quality control (QC) samples, µl of relevant standard spiking solution was added. For blank samples, µl of methanol / water (50:50 v/v) was added. 0 µl of 1% formic acid in water was then added and mixed well. Sample Preparation Compound: Matrix: Tenofovir Plasma Cartridge type: SOLA CX 96 well plate mg/2 ml 609-002 Condition: Application: Wash 1: Wash 2: Elution: Apply 0.5 ml methanol then 0.5 ml water Apply all of the spiked sample to the SOLA CX plate Apply 500 µl 1% formic acid in water Apply 500 µl 1% formic acid in methanol Apply 2 x 250 µl % ammonia solution in methanol. Evaporate to dryness under nitrogen at 40 C and reconstitute in 0 µl water / methanol (90: v/v). Mix well. Separation Conditions Instrumentation: Thermo Scientific TM Accela TM 600 Column: Hypersil GOLD, 1.9 µm, 50 2.1 mm 25002-0521 Mobile phase A: 25 mm ammonium acetate (ph 5) Mobile phase B: methanol Gradient: 0% 0% B in 1 minute Flow rate: 0.8 ml/min Column temperature: 40 C

Injection details: µl Injection wash solvent 1: water / acetonitrile (80: v/v) Injection wash solvent 2: IPA / acetonitrile / acetone (45:45: v/v/v) 3 MS Conditions Instrumentation: Thermo Scientific TM TSQ Vantage TM MS Ionization conditions: HESI Polarity: Positive Spray Voltage (V): 00 Vaporizer temp ( C): 350 Sheath gas pressure (Arb): 60 Aux gas pressure (Arb): 40 Capillary temp ( C): 0 Collision pressure (mtorr): 1.5 Scan time (s): 0.02 Q1 (FWHM) (Da): 0.7 Q3 (FWHM) (Da): 0.7 Compound: Tenofovir Parent (m/z): 288.1 Products (m/z): 176.2 Collision energy: 24 S-lens: 115 Data Processing Software: Thermo Scientific TM LCQUAN TM Results Chromatography The Hypersil GOLD UHPLC column gave excellent peak shape. The chromatography of the QC at 500 ng/ml is shown in Figure 2. The chromatography of the LOQ at 1 ng/ml is shown in Figure 3. The tenofovir peak at 0.8 minutes is well separated from the interference peak at 1.05 minutes. 0 90 80 70 60 Relative Abundance 50 40 0 0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 Time (min) Figure 2: Representative chromatogram of tenofovir SRM, extracted from plasma at 500 ng/ml

4 0 90 80 70 60 Relative Abundance 50 40 0 0.0 0.5 1.0 1.5 2.0 Time (min) Figure 3: Chromatogram of tenofovir SRM, extracted from plasma at 1 ng/ml Linearity Extracted tenofovir standards from plasma gave a linear calibration curve over the dynamic range of 1 to 00 ng/ml with an r 2 coefficient of 0.998 (Figure 4 and Table 1). 35 25 Area Ratio 15 5 0 0 400 600 800 00 Figure 4: Tenofovir linearity over the dynamic range 1 to 00 ng/ml Standard Specified Calculated %Diff S1 1 0.848-15 S2 50 56.0 12 S3 0 7 7 S4 500 487-3 S5 750 725-3 S6 00 3 Table 1: Accuracy data for 6 extracted tenofovir standards over the linear range 1 to 00 ng/ml

Accuracy and Precision QC samples were run in replicates of six at a concentration of 500 ng/ml. The precision of the QC level was < 3.7% CV (Table 2). Standard Average Calculated (n=6) %CV QC 500 451 3.7 Table 2: Average precision data for six replicate QCs for tenofovir Recovery Overspikes (post extraction fortified blank extracts) were run in triplicate at a concentration of 500 ng/ml and used to calculate the percentage recovery level for tenofovir of 88.5% (Table 3). Application Note 687 Standard Response (n=3) % Recovery Average QC area response 3275534 Average overspike area response 3702982 Table 3. Recovery data for tenofovir Conclusion SOLA CX SPE and Hypersil GOLD products allow for a simple extraction and quantification of tenofovir from plasma. A LOQ of 1 ng/ml for tenofovir in plasma was achieved. Extraction recovery was high >88%. The method showed excellent precision with %RSD (n=6) <4% at 500 ng/ml. The method on SOLA CX SPE was extremely reproducible. There was no need for an internal standard that would have been essential when using a conventional loose-packed SPE product. 88.5 For Clinical Research Use Only. Not For Clinical Diagnostics. thermoscientific.com/sola-spe 13 Thermo Fisher Scientific Inc. All rights reserved. Viread is a registered trademark of Gilead Sciences, Inc. All other trademarks are the property of Thermo Fisher Scientific Inc. and its subsidiaries. This information is presented as an example of the capabilities of Thermo Fisher Scientific Inc. products. It is not intended to encourage use of these products in any manners that might infringe the intellectual property rights of others. Specifications, terms and pricing are subject to change. Not all products are available in all countries. Please consult your local sales representative for details. USA and Canada +1 800 332 3331 France +33 (0)1 60 92 48 34 Germany +49 (0) 2423 9431 or 21 United Kingdom +44 (0)1928 5341 Japan +81 3 5826 1615 AN687_E 03/13S China +86 21 68654588 +86 84193588 +86 83145199 800 8 5118 India +91 22 6742 9494 +91 27 1766 2352 Australia 1 0 735 292 (free call domestic) New Zealand 0800 933 966 (free call domestic) All Other Enquiries +44 (0) 1928 534 050 Technical Support North America +1 800 332 3331 Outside North America +44 (0) 1928 534 440